Market Cap 13.30B
Revenue (ttm) 4.00B
Net Income (ttm) 421.36M
EPS (ttm) N/A
PE Ratio 26.16
Forward PE 21.62
Profit Margin 10.54%
Debt to Equity Ratio 0.00
Volume 817,600
Avg Vol 1,013,840
Day's Range N/A - N/A
Shares Out 72.49M
Stochastic %K 81%
Beta 1.64
Analysts Strong Sell
Price Target $234.25

Company Profile

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package to treat adults and teens from mild to severe malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 602 742 2000
Address:
410 North Scottsdale Road, Suite 1300, Tempe, United States
StockAnalyticsAI
StockAnalyticsAI Jun. 23 at 4:02 PM
$ALGN Deep Dive https://youtu.be/8nNLYj-j1kY?si=ObnmXSLBrW1TcnQi
0 · Reply
leomega
leomega Jun. 18 at 4:37 AM
$ALGN adding
0 · Reply
swingingtech
swingingtech Jun. 17 at 7:13 PM
$CRL $ALGN $ENPH $FSLR https://wallstreetwaves.com/tuesdays-market-weakness-declines-in-healthcare-technology-and-communications-sectors/
0 · Reply
UncleStock
UncleStock Jun. 2 at 1:36 AM
$EXPI $ALGN $STRA suggested for #3dprinting - value screen: https://zpr.io/6CKUw
0 · Reply
HANR
HANR May. 31 at 3:01 PM
$IXHL $ALGN $VVOS Absolutely spot on. History has a way of rhyming in biotech TRIL's move from $0.23 to $23 under a big pharma buyout sets the tone perfectly. The market repeatedly rewards simplicity, scalability, and unmet needs, and IXHL checks all the boxes: First-in-class oral treatment for OSA, targeting a market with over 1 billion patients globally. FDA fast-tracked approval into Phase 3, even before Phase 2 readout a rarity that signals serious underlying confidence. No competitor in oral form. Unlike ALGN’s invasive solution or VVOS’s false starts, IXHL is lean, affordable, and scalable. You nailed it: the market is tired of complexity. Investors, institutions, and acquirers alike are hungry for clear, efficient solutions, and IXHL is a textbook example of what acquisition targets look like before the explosion. This is how generational trades are born. Appreciate your insight only a few see the whole chessboard before the first major move.
1 · Reply
CantNameThatTune
CantNameThatTune May. 31 at 12:06 PM
$IXHL Big picture monkeys! Back in '20-'21, we had TRIL show up. 23 cents to $23. Pfizer bought them out for $2.2 billion. As of now, they've never had anything get out of Phase 2 for years. At the same time, $ALGN took off. Align does wearable sleep apnea devices but you have to have an expensive procedure to implant the device. Sure enough, that's when $VVOS showed up. Simpler, easier, more affordable. It went on its initial huge run to the upside and failed. At this point, Align has dropped from $750 to $180 as their earnings have fallen. Still PE 32. VVOS has its issues and is a continual non starter for everyone. As for IXHL? The world wants simple and easy. That's why IXHL gets bought out immediately and I've already previously indicated who the acquiring company is. For now, you're on a need to know basis. This is all you need to know for now...
1 · Reply
4PaulWalker
4PaulWalker May. 21 at 7:52 PM
$ALGN algos straight dumping here def buying more
0 · Reply
UncleStock
UncleStock May. 21 at 5:24 PM
$EXPI $ALGN $STRA suggested for #3dprinting - value screen: https://zpr.io/6CKUw
0 · Reply
OsitoPolar
OsitoPolar May. 16 at 12:45 AM
$ALGN Damn, 5% tomorrow? Currently up ~2% in overnight. “Align gets approval for dental-alignment device, ‘Invisalign Palatal Expander System’ in China. Said to be commercially available in second half of the year.” - Dow Jones
0 · Reply
smartkarma
smartkarma May. 14 at 10:03 AM
$ALGN | Align Technology: Innovative Product Offerings "Align Technology, a key player in the dental technology sector, has shown a mixed performance in its first quarter results for 2025. The company,..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/align-technology-innovative-product-offerings
0 · Reply
Latest News on ALGN
Align Technology Deserves A Rerate

Jun 20, 2025, 4:29 AM EDT - 5 days ago

Align Technology Deserves A Rerate


Align Technology to Speak at Upcoming Financial Conferences

May 1, 2025, 8:30 AM EDT - 7 weeks ago

Align Technology to Speak at Upcoming Financial Conferences


Align Technology, Inc. (ALGN) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 8:30 PM EDT - 7 weeks ago

Align Technology, Inc. (ALGN) Q1 2025 Earnings Call Transcript


Align Technology Announces First Quarter 2025 Financial Results

Apr 30, 2025, 4:15 PM EDT - 7 weeks ago

Align Technology Announces First Quarter 2025 Financial Results


Align Technology to Host Investor Day on May 6, 2025

Apr 2, 2025, 2:06 PM EDT - 2 months ago

Align Technology to Host Investor Day on May 6, 2025


Align Technology: Brace Yourself, This Stock Is Undervalued

Mar 7, 2025, 11:28 AM EST - 3 months ago

Align Technology: Brace Yourself, This Stock Is Undervalued


Align Technology Announces $225 Million Open Market Repurchase

Feb 25, 2025, 8:30 AM EST - 4 months ago

Align Technology Announces $225 Million Open Market Repurchase


These two 2024 laggards are positioned for a comeback

Feb 23, 2025, 3:41 AM EST - 4 months ago

These two 2024 laggards are positioned for a comeback

VVV


Align Technology, Inc. (ALGN) Q4 2024 Earnings Call Transcript

Feb 5, 2025, 6:20 PM EST - 4 months ago

Align Technology, Inc. (ALGN) Q4 2024 Earnings Call Transcript


Align Technology: A Change In Plans After Mixed Q3 Earnings

Oct 27, 2024, 2:19 PM EDT - 8 months ago

Align Technology: A Change In Plans After Mixed Q3 Earnings


Align Technology Announces $275 Million Open Market Repurchase

Oct 25, 2024, 8:30 AM EDT - 8 months ago

Align Technology Announces $275 Million Open Market Repurchase


Align Technology, Inc. (ALGN) Q3 2024 Earnings Call Transcript

Oct 23, 2024, 8:31 PM EDT - 8 months ago

Align Technology, Inc. (ALGN) Q3 2024 Earnings Call Transcript


ALIGN TECHNOLOGY ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS

Oct 23, 2024, 4:03 PM EDT - 8 months ago

ALIGN TECHNOLOGY ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS


Align Technology to Speak at Upcoming Financial Conference

Sep 4, 2024, 4:01 PM EDT - 10 months ago

Align Technology to Speak at Upcoming Financial Conference


Align Technology Announces New Regional Leadership Roles

Sep 3, 2024, 6:10 PM EDT - 10 months ago

Align Technology Announces New Regional Leadership Roles


Align Technology: Mixed Earnings Sparks Sell-Off

Aug 14, 2024, 5:03 PM EDT - 11 months ago

Align Technology: Mixed Earnings Sparks Sell-Off


StockAnalyticsAI
StockAnalyticsAI Jun. 23 at 4:02 PM
$ALGN Deep Dive https://youtu.be/8nNLYj-j1kY?si=ObnmXSLBrW1TcnQi
0 · Reply
leomega
leomega Jun. 18 at 4:37 AM
$ALGN adding
0 · Reply
swingingtech
swingingtech Jun. 17 at 7:13 PM
$CRL $ALGN $ENPH $FSLR https://wallstreetwaves.com/tuesdays-market-weakness-declines-in-healthcare-technology-and-communications-sectors/
0 · Reply
UncleStock
UncleStock Jun. 2 at 1:36 AM
$EXPI $ALGN $STRA suggested for #3dprinting - value screen: https://zpr.io/6CKUw
0 · Reply
HANR
HANR May. 31 at 3:01 PM
$IXHL $ALGN $VVOS Absolutely spot on. History has a way of rhyming in biotech TRIL's move from $0.23 to $23 under a big pharma buyout sets the tone perfectly. The market repeatedly rewards simplicity, scalability, and unmet needs, and IXHL checks all the boxes: First-in-class oral treatment for OSA, targeting a market with over 1 billion patients globally. FDA fast-tracked approval into Phase 3, even before Phase 2 readout a rarity that signals serious underlying confidence. No competitor in oral form. Unlike ALGN’s invasive solution or VVOS’s false starts, IXHL is lean, affordable, and scalable. You nailed it: the market is tired of complexity. Investors, institutions, and acquirers alike are hungry for clear, efficient solutions, and IXHL is a textbook example of what acquisition targets look like before the explosion. This is how generational trades are born. Appreciate your insight only a few see the whole chessboard before the first major move.
1 · Reply
CantNameThatTune
CantNameThatTune May. 31 at 12:06 PM
$IXHL Big picture monkeys! Back in '20-'21, we had TRIL show up. 23 cents to $23. Pfizer bought them out for $2.2 billion. As of now, they've never had anything get out of Phase 2 for years. At the same time, $ALGN took off. Align does wearable sleep apnea devices but you have to have an expensive procedure to implant the device. Sure enough, that's when $VVOS showed up. Simpler, easier, more affordable. It went on its initial huge run to the upside and failed. At this point, Align has dropped from $750 to $180 as their earnings have fallen. Still PE 32. VVOS has its issues and is a continual non starter for everyone. As for IXHL? The world wants simple and easy. That's why IXHL gets bought out immediately and I've already previously indicated who the acquiring company is. For now, you're on a need to know basis. This is all you need to know for now...
1 · Reply
4PaulWalker
4PaulWalker May. 21 at 7:52 PM
$ALGN algos straight dumping here def buying more
0 · Reply
UncleStock
UncleStock May. 21 at 5:24 PM
$EXPI $ALGN $STRA suggested for #3dprinting - value screen: https://zpr.io/6CKUw
0 · Reply
OsitoPolar
OsitoPolar May. 16 at 12:45 AM
$ALGN Damn, 5% tomorrow? Currently up ~2% in overnight. “Align gets approval for dental-alignment device, ‘Invisalign Palatal Expander System’ in China. Said to be commercially available in second half of the year.” - Dow Jones
0 · Reply
smartkarma
smartkarma May. 14 at 10:03 AM
$ALGN | Align Technology: Innovative Product Offerings "Align Technology, a key player in the dental technology sector, has shown a mixed performance in its first quarter results for 2025. The company,..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/align-technology-innovative-product-offerings
0 · Reply
4PaulWalker
4PaulWalker May. 9 at 3:28 AM
$ALGN finally a good day! Keep rolling!!!!
0 · Reply
UncleStock
UncleStock May. 8 at 11:56 PM
$EXPI $ALGN $STRA suggested for #3dprinting - value screen: https://zpr.io/6CKUw
0 · Reply
UncleStock
UncleStock May. 7 at 2:00 AM
$EXPI $KOPN $ALGN suggested for #3dprinting - value screen: https://zpr.io/6CKUw
0 · Reply
Estimize
Estimize May. 1 at 5:36 PM
$ALGN reported 2.13 EPS and 979.26 revenue for Q1. http://www.estimize.com/intro/algn?chart=historical&metric_name=eps&utm_content=ALGN&utm
0 · Reply
mcedillo
mcedillo May. 1 at 4:35 PM
$ALGN welp so much for gap up
0 · Reply
Trade_best
Trade_best May. 1 at 4:04 PM
$ALGN going back down?
0 · Reply
joshaliman
joshaliman May. 1 at 3:11 PM
$ALGN why this shit is going down again. I thought its going to touch $220 today. whenever i take it goes down
1 · Reply
JarvisFlow
JarvisFlow May. 1 at 2:28 PM
Piper Sandler updates rating for Align Technology ( $ALGN ) to Overweight, target set at 235 → 250.
0 · Reply
IM_AP
IM_AP May. 1 at 12:08 PM
$ALGN what is the typical play after on this ticker? Will it run or give it up? I understand it's hard to say. But just anybody who has followed this ticker for a while has any insights??
1 · Reply
OpenOutcrier
OpenOutcrier May. 1 at 12:03 PM
$ALGN (+10.2% pre) Align raises annual revenue growth forecast after quarterly results beat https://ooc.bz/l/63135
0 · Reply
JarvisFlow
JarvisFlow May. 1 at 11:30 AM
Needham updates rating for Align Technology ( $ALGN ) to Hold.
0 · Reply
healthcareguru
healthcareguru May. 1 at 4:55 AM
$ALGN was the most known 1Q beat for entirety of Wall St…that’s why it was running into the news (aka: easy af guide 😂). Smart $ is shorting the crap outta this pop into 100% guaranteed consumer recession coming now. Yuck. 👎 Commoditized trash.
2 · Reply